Collaboration is the cornerstone of our scientific leadership. Maverick Jeelan maintains exclusive technical and commercial alliances with globally recognized industry leaders in New Zealand and Germany: Enzogenol® and KLAPP Skin Care Science.
Partnering with world-renowned pioneers in New Zealand and Germany to deliver certified botanical purity and advanced dermatological science:
The World's Purest Pine Bark Extract
Enzogenol® is a 100% natural, internationally patented extract derived from the bark of sustainable, pristine New Zealand grown Pinus radiata trees. Using an environmentally friendly pure water-only extraction method (free from chemical solvents), Enzogenol® concentrates nature's most potent blend of broad-spectrum antioxidant and anti-inflammatory bioflavonoids (guaranteed ≥80% proanthocyanidins). Supported by extensive clinical research for cognitive vitality, cardiovascular support, cellular protection, and healthy aging.
Professional Skincare Made in Germany
KLAPP Skin Care Science is an internationally acclaimed German pioneer in professional, dermatologically tested skincare and clinical beauty concepts "Made in Germany". Trusted by over 30,000 skincare experts, dermatologists, and medical beauty institutes in more than 60 countries worldwide. KLAPP combines cutting-edge molecular cosmetic science with highly concentrated active ingredients, specialized peptides, and botanical extracts to deliver visible, clinically verified skin transformation.
How our collaborative relationships translate into direct clinical and commercial benefits for our healthcare clients:
Direct bilateral licensing of formulation techniques, crystal dissolution enhancements, and clinical device firmware.
Joint regulatory filings, shared clinical safety dossiers, and mutual compliance with FDA, CE, and Indian CDSCO requirements.
Optimized global logistics ensuring uninterrupted raw material availability and climate-controlled freight handling.
Peer-reviewed research and hospital clinical trials validating therapeutic efficacy across diverse patient cohorts.
Are you a global manufacturer, research university, or medical device innovator looking to expand into the Indian subcontinent or co-develop therapeutic formulations?
Submit your organization profile to connect with our transnational business development board.
